Compounds > rastim 30 dkv
Page last updated: 2024-12-08

rastim 30 dkv

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

Rastim 30 DKV: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID147467
MeSH IDM0227277

Synonyms (22)

Synonym
HMS1695E08
rastim 30 dkv
phenylmethyl 2-oxo-3(2h)-benzothiazoleacetate
3(2h)-benzothiazoleacetic acid, 2-oxo-, phenylmethyl ester
2-oxo-3(2h)-benzothiazoleacetic acid phenylmethyl ester
3-(benzyloxycarbonylmethyl)benzothiazolinone
brn 1145411
ccris 6835
benzyl (2-oxo-1,3-benzothiazol-3(2h)-yl)acetate
STK895226
AKOS000648991
benzyl 2-(2-oxo-1,3-benzothiazol-3-yl)acetate
119584-53-1
3-(benzyloxycarbonylmethyl)-2-benzothiazolinone
benzyl 2-(2-oxo-2,3-dihydro-1,3-benzothiazol-3-yl)acetate
CCG-120029
F1641-0023
benzyl 2-(2-oxobenzo[d]thiazol-3(2h)-yl)acetate
AE-641/05583011
Z111715610
3-(benzyloxycarbonyl-methyl)benzothiazolin-2-on
DTXSID00923008
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
thiazoles
[no description available]		2.69301,3-thiazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
ConditionIndicatedRelationship StrengthStudiesTrials
Encephalitis, Polio
[description not available]		02.0610
Poliomyelitis
An acute infectious disease of humans, particularly children, caused by any of three serotypes of human poliovirus (POLIOVIRUS). Usually the infection is limited to the gastrointestinal tract and nasopharynx, and is often asymptomatic. The central nervous system, primarily the spinal cord, may be affected, leading to rapidly progressive paralysis, coarse FASCICULATION and hyporeflexia. Motor neurons are primarily affected. Encephalitis may also occur. The virus replicates in the nervous system, and may cause significant neuronal loss, most notably in the spinal cord. A rare related condition, nonpoliovirus poliomyelitis, may result from infections with nonpoliovirus enteroviruses. (From Adams et al., Principles of Neurology, 6th ed, pp764-5)		02.0610
Hay Fever
[description not available]		02.0110
Rhinitis, Allergic, Seasonal
Allergic rhinitis that occurs at the same time every year. It is characterized by acute CONJUNCTIVITIS with lacrimation and ITCHING, and regarded as an allergic condition triggered by specific ALLERGENS.		02.0110